287 related articles for article (PubMed ID: 16648858)
1. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.
Ferby I; Reschke M; Kudlacek O; Knyazev P; Pantè G; Amann K; Sommergruber W; Kraut N; Ullrich A; Fässler R; Klein R
Nat Med; 2006 May; 12(5):568-73. PubMed ID: 16648858
[TBL] [Abstract][Full Text] [Related]
2. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.
Siu A; Virtanen C; Jongstra J
Oncotarget; 2011 Dec; 2(12):1134-44. PubMed ID: 22193779
[TBL] [Abstract][Full Text] [Related]
3. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
[TBL] [Abstract][Full Text] [Related]
4. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
[TBL] [Abstract][Full Text] [Related]
5. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
Zhang H; Liu W; Wang Z; Meng L; Wang Y; Yan H; Li L
Tumori; 2018 Jun; 104(3):221-231. PubMed ID: 29714661
[TBL] [Abstract][Full Text] [Related]
6. The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.
Chang X; Izumchenko E; Solis LM; Kim MS; Chatterjee A; Ling S; Monitto CL; Harari PM; Hidalgo M; Goodman SN; Wistuba II; Bedi A; Sidransky D
PLoS One; 2013; 8(7):e68966. PubMed ID: 23935914
[TBL] [Abstract][Full Text] [Related]
7. The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.
Izumchenko E; Chang X; Michailidi C; Kagohara L; Ravi R; Paz K; Brait M; Hoque MO; Ling S; Bedi A; Sidransky D
Cancer Res; 2014 Jul; 74(14):3995-4005. PubMed ID: 24830724
[TBL] [Abstract][Full Text] [Related]
8. Mutation of epidermal growth factor receptor is associated with MIG6 expression.
Nagashima T; Ushikoshi-Nakayama R; Suenaga A; Ide K; Yumoto N; Naruo Y; Takahashi K; Saeki Y; Taiji M; Tanaka H; Tsai SF; Hatakeyama M
FEBS J; 2009 Sep; 276(18):5239-51. PubMed ID: 19674104
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.
Naruo Y; Nagashima T; Ushikoshi-Nakayama R; Saeki Y; Nakakuki T; Naka T; Tanaka H; Tsai SF; Okada-Hatakeyama M
BMC Syst Biol; 2011 Feb; 5():29. PubMed ID: 21333004
[TBL] [Abstract][Full Text] [Related]
10. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
[TBL] [Abstract][Full Text] [Related]
11. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
Menezes SV; Kovacevic Z; Richardson DR
J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310
[TBL] [Abstract][Full Text] [Related]
12. DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling.
Park SY; Choi HK; Seo JS; Yoo JY; Jeong JW; Choi Y; Choi KC; Yoon HG
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2722-30. PubMed ID: 26239118
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.
Reschke M; Ferby I; Stepniak E; Seitzer N; Horst D; Wagner EF; Ullrich A
Hepatology; 2010 Apr; 51(4):1383-90. PubMed ID: 20044804
[TBL] [Abstract][Full Text] [Related]
14. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
Walsh AM; Lazzara MJ
J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
16. The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.
Chun KS; Lao HC; Langenbach R
J Biol Chem; 2010 Dec; 285(51):39672-81. PubMed ID: 20959465
[TBL] [Abstract][Full Text] [Related]
17. Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6.
Sun M; Cai J; Anderson RA; Sun Y
J Biol Chem; 2016 Oct; 291(41):21461-21473. PubMed ID: 27557663
[TBL] [Abstract][Full Text] [Related]
18. Mig6 reduces inflammatory mediators production by regulating the activation of EGFR in LPS-induced endotoxemia.
Chen W; Zhong H; Wang X; Pang Q; Zhuang J; Hu J; Chen Y; Hu J; Liu J; Tang J
J Cell Physiol; 2018 Sep; 233(9):6975-6983. PubMed ID: 29336487
[TBL] [Abstract][Full Text] [Related]
19. A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation.
Frosi Y; Anastasi S; Ballarò C; Varsano G; Castellani L; Maspero E; Polo S; Alemà S; Segatto O
J Cell Biol; 2010 May; 189(3):557-71. PubMed ID: 20421427
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
